Physician

Frank Richard Noodleman, M.D.

According to 2025 Medicare claims, Frank Noodleman, M.D. (NPI: 1285772152) practices dermatology in the Salinas, CA market, with the plurality of this provider's patient population coming from Monterey, CA. This provider's primary affiliated billing organization is CSI MEDICAL GROUP (NPI: 1871909804; TIN: 471108040) and primary practice location at 95019-3135.

Noodleman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,850 traditional Medicare patients, billed 8,368 HCPCS/CPT codes, and received $939,618 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,213 prescription claims across 790 beneficiaries totaling $1,778,137 in drug costs, led by Humira Pen (Adalimumab). Open Payments data shows 173 records totaling $3,854. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $207,359 to $939,618. Similarly, Part D prescription costs have moved sharply higher in recent years, from $52,583 to $1,778,137. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$470K$940K2015 Medicare payment: $207,359 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $212,659 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $243,564 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $376,193 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $501,440 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $693,921 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $729,456 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $888,716 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $916,886 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $939,618 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201542410,889$207,359
20165135,268$212,659
20171,0864,612$243,564
20181,5568,002$376,193
20191,5228,734$501,440
20201,55810,185$693,921
20211,57010,258$729,456
20221,75910,522$888,716
20231,6418,587$916,886
20241,8508,368$939,618

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.7M2015 Drug cost: $52,583 (USD; Tot_Drug_Cst)2016 Drug cost: $68,096 (USD; Tot_Drug_Cst)2017 Drug cost: $166,686 (USD; Tot_Drug_Cst)2018 Drug cost: $304,598 (USD; Tot_Drug_Cst)2019 Drug cost: $492,429 (USD; Tot_Drug_Cst)2020 Drug cost: $1,015,774 (USD; Tot_Drug_Cst)2021 Drug cost: $1,718,721 (USD; Tot_Drug_Cst)2022 Drug cost: $1,978,029 (USD; Tot_Drug_Cst)2023 Drug cost: $2,650,088 (USD; Tot_Drug_Cst)2024 Drug cost: $1,778,137 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015151389$52,583
2016176467$68,096
2017376917$166,686
20184951,205$304,598
20195421,423$492,429
20206551,789$1,015,774
20216081,681$1,718,721
20226651,857$1,978,029
20237632,354$2,650,088
20247902,213$1,778,137

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths9611,256$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,4462,408$68
17000Destruction of precancer skin growth, 1 growth334438$45
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more272317$42
17003Destruction of precancer skin growth, 2-14 growths2431,163$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira PenAdalimumab421,400$336,970
OtezlaApremilast752,250$336,410
Dupixent PenDupilumab401,120$206,742
Humira(Cf) PenAdalimumab13364$88,194
Taltz AutoinjectorIxekizumab13364$87,148

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.173$3,854ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Frank Richard Noodleman, M.D.?

Tedicare shows public-source Medicare data for Frank Richard Noodleman, M.D. (NPI 1285772152), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Frank Richard Noodleman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Frank Richard Noodleman, M.D.?

Frank Richard Noodleman, M.D. is linked to CSI MEDICAL GROUP (billing NPI 1871909804) in the available physician profile data.

Does Frank Richard Noodleman, M.D. have Open Payments data?

Frank Richard Noodleman, M.D. has 173 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.